111 (NASDAQ:YI) Trading Down 2.2% – Here’s Why

111, Inc. Sponsored ADR (NASDAQ:YI) traded down 2.2% during trading on Wednesday . The company traded as low as $3.01 and last traded at $3.13. Approximately 1,657 shares traded hands during mid-day trading, a decline of 82% from the average session volume of 8,994 shares. The stock had previously closed at $3.20.

Analyst Ratings Changes

Separately, Weiss Ratings lowered 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Monday, August 31st. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock currently has a consensus rating of “Sell”.

111 Stock Down 2.2%

The stock has a market capitalization of $27.51 million, a P/E ratio of -2.24 and a beta of 0.64. The company has a fifty day simple moving average of $3.70 and a two-hundred day simple moving average of $5.22.

Insider Buying and Selling at 111

In related news, Director Jian David Sun sold 111,100 shares of the business’s stock in a transaction that occurred on Thursday, June 11th. The stock was sold at an average price of $0.23, for a total value of $25,553.00. Following the completion of the transaction, the director directly owned 472,011 shares in the company, valued at approximately $108,562.53. The trade was a 19.05% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders sold 263,820 shares of company stock worth $60,679. Insiders own 43.90% of the company’s stock.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.